Hosted on MSN
Biocurious: Dimerix could be riding big and beautiful kidney drug success earlier than expected
With the FDA’s blessing, Dimerix will use phase III trial endpoints that could lead to accelerated approval for its kidney disease drug Dimerix is confident of phase III success because an expert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results